Jaw pain relief: which needle method works best?
NCT ID NCT06766851
First seen Jun 26, 2026 · Last updated Aug 13, 2026 · Updated 3 times
Summary
This study tested two techniques for washing out the jaw joint (arthrocentesis) in 30 adults with TMJ disorders. One method used a single needle, the other a catheter. Researchers measured pain and how wide patients could open their mouths. The goal was to see which approach provides better symptom relief.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Arthrocentesis (joint washing procedure)
- What this could lead to
- If one method proves better, it could offer a simpler or more effective way to ease TMJ pain and improve jaw movement.
- What could go wrong
- This is a small, completed study with only 30 participants, so results may not apply to everyone. The procedure itself carries minor risks like infection or discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Patients included in this study were adult individuals aged 18 years and older who were diagnosed with stage 3 or higher temporomandibular joint (TMJ) disorder according to the Wilkes classification, based on magnetic resonance imaging (MRI) in addition to clinical evaluation. Eligible patients had unilateral internal TMJ disorder and exhibited clinical symptoms such as TMJ-related pain and/or joint sounds, and limited mouth opening. Furthermore, only patients whose symptoms persisted despite at least one month of occlusal splint therapy were included. Exclusion criteria were as follows: patients diagnosed with myofascial pain or muscle-related functional limitation; those who had previously undergone intra-articular injection or other invasive procedures involving the TMJ; patients with connective tissue diseases such as rheumatoid arthritis or with neurological disorders; patients with a history of major jaw trauma; and individuals with psychiatric disorders or a history of substance abuse.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthrocentesis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eskişehir Osmangazi University
Eskişehir, 26480, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can viral markers predict who survives hepatitis b liver failure?
- Can a Blood-Based injection and botox ease jaw joint pain?
- Could a single shot replace daily HIV pills?
- Sleep hormone melatonin put to the test against lupus fatigue and inflammation
- Can early jaw treatment in children prevent major surgery later?
- Brain training may help prevent alcohol relapse after withdrawal